GB1037143A - Polypeptides - Google Patents

Polypeptides

Info

Publication number
GB1037143A
GB1037143A GB47570/64A GB4757064A GB1037143A GB 1037143 A GB1037143 A GB 1037143A GB 47570/64 A GB47570/64 A GB 47570/64A GB 4757064 A GB4757064 A GB 4757064A GB 1037143 A GB1037143 A GB 1037143A
Authority
GB
United Kingdom
Prior art keywords
boc
amino
acid
groups
onp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB47570/64A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of GB1037143A publication Critical patent/GB1037143A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/22Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Peptides of the formula X-phe-ile-gly-leu-met-NH2 where X is H or the acyl residue of an a -amino acid excepting L-lysine and L-alanine, or the acyl residue of a dipeptide with the exception of H-asp(OH)-ala-, its protected derivatives having the amino groups and the carboxyl groups not involved in the formation of peptide links blocked by protecting groups capable of being removed by acidolysis or hydrogenolysis and their non-toxic, pharmaceutically acceptable acid addition salts are prepared by reacting an a -amino-acid or a polypeptide with another polypeptide whose amino acid sequences are part of the above sequence, the amino and carboxylic acid groups not involved in the condensation being suitably protected and, if desired, removed from the final product. Intermediates prepared include: BOC-phe-ile-gly OEt and the free acid; BOC - pro - ONP; BOC - met - ONP and BOC - asp (NH2) - BOC - lys OMe (where BOC = t-butyloxy carbonyl and NP = p-nitrophenyl). Pharmaceutical compositions comprise the compounds of the invention together with a pharmaceutically acceptable carrier. The compositions, which are hypotensive agents, may be in a form suitable for parenteral administration.
GB47570/64A 1963-11-28 1964-11-23 Polypeptides Expired GB1037143A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2422463 1963-11-28

Publications (1)

Publication Number Publication Date
GB1037143A true GB1037143A (en) 1966-07-27

Family

ID=11212639

Family Applications (1)

Application Number Title Priority Date Filing Date
GB47570/64A Expired GB1037143A (en) 1963-11-28 1964-11-23 Polypeptides

Country Status (3)

Country Link
BE (1) BE656369A (en)
DE (1) DE1518288A1 (en)
GB (1) GB1037143A (en)

Also Published As

Publication number Publication date
DE1518288A1 (en) 1969-07-24
BE656369A (en) 1965-03-16

Similar Documents

Publication Publication Date Title
DE68928321D1 (en) Antiaggregative peptides
GB1528336A (en) Compounds compositions and methods of their use
SI9420001B (en) Polypeptide bombesin antagonists
KR870007203A (en) Methods for making peptides
GB1461437A (en) Peptides and process for preparing them
US3488726A (en) R-l-methionyl-glycyl octapeptides related to caerulein and intermediates therefor
DE3467581D1 (en) Gastric secretion inhibiting peptide derivatives, process for their preparation and medicines containing them
GB1037143A (en) Polypeptides
GB1109086A (en) Polypeptides
GB1002041A (en) New polypeptides and process for their manufacture
ES281304A1 (en) A procedure for the preparation of new hypotensive polypeptides (Machine-translation by Google Translate, not legally binding)
GB1309150A (en) Acthactive peptides and process for their manufacture
DE3267380D1 (en) Peptides and pseudopeptides in which the n terminus bears two substituents
GB992957A (en) New decapeptides and their manufacture
GB997849A (en) Polypeptides
GB1007777A (en) Improvements in or relating to hendecapeptides
ES316390A1 (en) Peptides having an adrenocorticotropic hormone action and process for their manufacture
GB1329618A (en) Peptides having adrenocorticotropic activity and process for their preparation
GB1353827A (en) Acthaction peptides and process for their manufacture
GB1462493A (en) Trypsin inhibitors and process for the production thereof
GB1243035A (en) New hypocalcaemic peptides and processes for their manufacture
GB1046303A (en) Polypeptides
FR4219M (en)
GB1231494A (en)
ES416516A1 (en) A procedure for the preparation of nonapeptides. (Machine-translation by Google Translate, not legally binding)